Testing effectiveness (Phase 2)WithdrawnNCT06087731What this trial is testingEfficacy and Safety of Tocilizumab for TAOWho this might be right forTocilizumabThyroid Associated Ophthalmopathy Sun Yat-sen University
Post-approval studies (Phase 4)UnknownNCT01056419What this trial is testingThe Effect of Early Total Thyroidectomy in the Course of Graves' OrbitopathyWho this might be right forGraves' Ophthalmopathy Ankara University 40
Not applicableUnknownNCT04919694What this trial is testingCombination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated OphthalmopathyWho this might be right forThyroid Associated Ophthalmopathy Sun Yat-sen University 60
Post-approval studies (Phase 4)Ended earlyNCT01738243What this trial is testingHyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease University of California, Los Angeles 2
Not applicableStudy completedNCT04488406What this trial is testingGenetics and Epigenetics of Graves' OrbitopathyWho this might be right forGraves Ophthalmopathy University of Pisa 12
Large-scale testing (Phase 3)Study completedNCT06384547What this trial is testingA Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 231
Post-approval studies (Phase 4)Looking for participantsNCT07152366What this trial is testingEfficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.Who this might be right forThyroid Associated Ophthalmopathies Shanghai Changzheng Hospital 96
Not applicableStudy completedNCT01885533What this trial is testingPost-Radioiodine Graves' Management: The PRAGMA-StudyWho this might be right forGraves' Disease Newcastle-upon-Tyne Hospitals NHS Trust 803
Post-approval studies (Phase 4)UnknownNCT02339142What this trial is testingCombined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye DiseaseWho this might be right forGraves Ophthalmopathy University of British Columbia 100
Early research (Phase 1)Study completedNCT07142642What this trial is testingEvaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese ParticipantsWho this might be right forHealthy Volunteers Amgen 20
Testing effectiveness (Phase 2)UnknownNCT02373995What this trial is testingRole of the Microbiome in Graves' OrbitopathyWho this might be right forGraves' Disease Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 60
Post-approval studies (Phase 4)Study completedNCT01599273What this trial is testingTreatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone InjectionsWho this might be right forThyroid-associated Ophthalmopathy Yonsei University 50
Not applicableStudy completedNCT03535090What this trial is testingCoagulation After Intravenous Methylprednisolone AdministrationWho this might be right forGraves' DiseaseGraves OphthalmopathyBlood Coagulation+1 more Piotr Miskiewicz 26
Not applicableUnknownNCT01999790What this trial is testingComparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's OrbitopathyWho this might be right forGraves Ophthalmopathy University of Sao Paulo 40
Testing effectiveness (Phase 2)Looking for participantsNCT04936854What this trial is testingSirolimus vs Corticosteroids in Treatment of Thyroid Eye DiseaseWho this might be right forThyroid-Associated Ophthalmopathy Haukeland University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03922321What this trial is testingStudy of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)Who this might be right forGraves' Ophthalmopathy Immunovant Sciences GmbH 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT05049603What this trial is testingClinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 StudyWho this might be right forGraves' Orbitopathy University of Pisa 102
Not applicableStudy completedNCT00665795What this trial is testingMorphometric Analysis of Orbital Structures in Graves´ OrbitopathyWho this might be right forDysthyroid Orbitopathy University of Sao Paulo 80
Not applicableStudy completedNCT02693808What this trial is testingNew Treatment for Patients With Temporal Hollowing After Lateral Wall DecompressionWho this might be right forThyroid-Associated Ophthalmopathy Haukeland University Hospital 29
Testing effectiveness (Phase 2)Ended earlyNCT03938545What this trial is testingASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )Who this might be right forGraves' Ophthalmopathy (GO) Immunovant Sciences GmbH 65